Sepsis and COVID-19: Perspectives From a Sepsis Coordinator

Coronavirus disease 2019 (COVID-19) has brought difficulties and disruptions to all corners of the world. As a sepsis coordinator, I can attest that the scientific and healthcare community in the United States has been particularly... read more

Sepsis and COVID-19: Perspectives From a Sepsis Coordinator

COVID-19: A Critical Analysis of Chloroquine and Hydroxychloroquine Clinical Pharmacology

Chloroquine and hydroxychloroquine have been used for over 60 years in the treatment of malaria, amoebic liver abscess, and several rheumatological conditions, but their clinical pharmacology is not well understood. COVID-19... read more

COVID-19: A Critical Analysis of Chloroquine and Hydroxychloroquine Clinical Pharmacology

Hydroxychloroquine With or Without Azithromycin

Among patients hospitalized with mild-to-moderate COVID-19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care. A total of 667 patients... read more

Hydroxychloroquine With or Without Azithromycin

Training Multidisciplinary Healthcare Workers to Reinforce ICUs in Times of Need

ESICM is to carry out a C19 SPACE programme funded by the European Commission for the training of multidisciplinary healthcare professionals not regularly working in ICUs, to give extra support to ICUs during the COVID-19... read more

Training Multidisciplinary Healthcare Workers to Reinforce ICUs in Times of Need

Effect of Hydrocortisone on Mortality and Organ Support in Patients with Severe COVID-19

Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority... read more

Effect of Hydrocortisone on Mortality and Organ Support in Patients with Severe COVID-19

CDC Tells States How to Prepare for Covid-19 Vaccine by Early November

The Centers for Disease Control and Prevention has notified public health officials in all 50 states and five large cities to prepare to distribute a coronavirus vaccine to health care workers and other high-risk groups as... read more

CDC Tells States How to Prepare for Covid-19 Vaccine by Early November

Steroids Confirmed to Help Severely Ill COVID-19 Patients

In patients hospitalized with COVID-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those... read more

Steroids Confirmed to Help Severely Ill COVID-19 Patients

Obesity and the Risk of Intubation or Death in Patients with COVID-19

Among consecutive patients hospitalized with coronavirus disease 2019, obesity was an independent risk factor for intubation or death. A total of 305 patients were included in this study. We stratified patients by body... read more

Obesity and the Risk of Intubation or Death in Patients with COVID-19

Principles Guiding Non Pandemic Critical Care Research During a Pandemic

Deliberation about continuing non pandemic research should use objective, transparent criteria considering several aspects of the research process such as bedside and research staff safety, infection control, the informed... read more

Principles Guiding Non Pandemic Critical Care Research During a Pandemic

Asthma Among Hospitalized Patients with COVID-19 and Related Outcomes

Among hospitalized patients 65 years or younger with severe COVID-19, asthma diagnosis was not associated with worse outcomes, regardless of age, obesity, or other high-risk comorbidities. Future population-based studies... read more

Asthma Among Hospitalized Patients with COVID-19 and Related Outcomes

Awake Prone Positioning for COVID-19 Hypoxemic Respiratory Failure

Infection with SARS-CoV-2 can result in Coronavirus Disease–19 (COVID-19). While the majority of patients are asymptomatic or have mild disease, approximately 14% develop more severe disease including hypoxemic respiratory... read more

Awake Prone Positioning for COVID-19 Hypoxemic Respiratory Failure

Evaluation of SARS-CoV-2 Serology Assays Reveals a Range of Test Performance

Appropriate use and interpretation of serological tests for assessments of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, infection and potential immunity require accurate data on assay performance.... read more

Evaluation of SARS-CoV-2 Serology Assays Reveals a Range of Test Performance

When Should I Worry About a PE in a Patient with COVID-19

PE diagnosis in COVID-19 patients is challenging. Many of the features of PE, such as shortness of breath and hypoxemia, are very common in patients with COVID-19, even in the absence of PE. Further, the diagnostic tests... read more

Respiratory Support in Patients with COVID-19

Non-invasive respiratory support could be useful in treating COVID-19-related acute respiratory failure (ARF). A rational use of different techniques (oxygen therapy, CPAP, NIV or HFOT) by a trained pulmonologist could allow... read more

Respiratory Support in Patients with COVID-19

Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children

Acute myocarditis with intense systemic inflammation and atypical Kawasaki disease is an emerging severe pediatric disease following SARS-CoV-2 infection. Early recognition of this disease is needed and referral to an expert... read more

Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children

Variation in Hospital Visitor & ICU Communication Policies Due to COVID-19

A new study documents how 49 of those hospitals reacted, and how those efforts varied. It finds that virtually all hospitals put in place a "no visitors" blanket policy. But 59% of hospitals did allow some exceptions to this... read more

Variation in Hospital Visitor & ICU Communication Policies Due to COVID-19

How AI is Reshaping Healthcare During COVID-19

As the healthcare and pharmaceutical industries rush to tackle a wide range of COVID-19 challenges, from developing treatments and sourcing medical supplies to mitigating outbreaks and racing towards a vaccine, the use of... read more

How AI is Reshaping Healthcare During COVID-19

Plasma Exchange in Critically Ill COVID-19 Patients

The spectrum of coronavirus disease 2019 (COVID-19) ranges from asymptomatic infection to respiratory failure and death of patients. Severely affected patients may develop a cytokine storm-like clinical syndrome with multi-organ... read more

Plasma Exchange in Critically Ill COVID-19 Patients

Prone Positioning in Non-intubated Patients with COVID-19

As the COVID-19 pandemic has put severe stress and strain on the capacity of hospitals around the world, concerted efforts have been made to evaluate therapeutics aimed at preventing the need for mechanical ventilation. The... read more

Prone Positioning in Non-intubated Patients with COVID-19